5 results
To determine the safety and efficacy of Dimebon in patients with mild to moderate Huntington Disease
The aim of this pilotstudy is to obtain data regarding feasibility, safety and costs of home-based electrical cardioversion
To determine the benefit of Dimebon as compared to placebo on the primary measure of cognition and memory, the Alzheimer*s Disease Assessment Scale * cognitive subscale (ADAS-cog); andTo determine the benefit of Dimebon as compared to placebo on theā¦
To evaluate the long-term safety and tolerability of Dimebon in AD patients who have successfully completed 26 weeks of blinded treatment in the CONNECTION Study (DIM14) (hereafter referred to as *CONNECTION*).
The aim of this pilotstudy is to obtain data regarding feasibility, safety and costs of home-based electrical cardioversion